These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 23859192)
1. Prevention of peritonitis in peritoneal dialysis. Segal JH; Messana JM Semin Dial; 2013; 26(4):494-502. PubMed ID: 23859192 [TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071 [TBL] [Abstract][Full Text] [Related]
3. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis. Mahaldar A; Weisz M; Kathuria P Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318 [TBL] [Abstract][Full Text] [Related]
4. Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis. Tsai CC; Yang PS; Liu CL; Wu CJ; Hsu YC; Cheng SP Am J Surg; 2018 Jan; 215(1):179-185. PubMed ID: 28341139 [TBL] [Abstract][Full Text] [Related]
5. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit. Davenport A; J Nephrol; 2012; 25(5):819-24. PubMed ID: 22241640 [TBL] [Abstract][Full Text] [Related]
6. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance. Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229 [TBL] [Abstract][Full Text] [Related]
7. Long-Term Exit-Site Gentamicin Prophylaxis and Gentamicin Resistance in a Peritoneal Dialysis Program. Chen SS; Sheth H; Piraino B; Bender F Perit Dial Int; 2016; 36(4):387-9. PubMed ID: 26634567 [TBL] [Abstract][Full Text] [Related]
8. [Prophylaxis and management of catheter-associated infections in peritoneal dialysis patients: recent studies and guidelines]. Kopriva-Altfahrt G; Moser E; Prokschi A; Kraus B; Kovarik J Wien Klin Wochenschr; 2005; 117 Suppl 6():73-82. PubMed ID: 16437337 [TBL] [Abstract][Full Text] [Related]
9. Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial. Wong PN; Tong GM; Wong YY; Lo KY; Chan SF; Lo MW; Lo KC; Ho LY; Tse CW; Mak SK; Wong AK Perit Dial Int; 2016; 36(3):340-6. PubMed ID: 27044796 [TBL] [Abstract][Full Text] [Related]
11. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial. Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW; Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790 [TBL] [Abstract][Full Text] [Related]
12. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Xu G; Tu W; Xu C Nephrol Dial Transplant; 2010 Feb; 25(2):587-92. PubMed ID: 19679557 [TBL] [Abstract][Full Text] [Related]
13. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site. Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524 [TBL] [Abstract][Full Text] [Related]
14. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis. Pierce DA; Williamson JC; Mauck VS; Russell GB; Palavecino E; Burkart JM Perit Dial Int; 2012; 32(5):525-30. PubMed ID: 22302770 [TBL] [Abstract][Full Text] [Related]
15. Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience. Aykut S; Caner C; Ozkan G; Ali C; Tugba A; Zeynep G; Taner C Ren Fail; 2010 Jan; 32(3):356-61. PubMed ID: 20370452 [TBL] [Abstract][Full Text] [Related]
16. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis. Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients. Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858 [TBL] [Abstract][Full Text] [Related]
18. [Importance of exit site care as peritonitis prophylaxis: experience in our centre]. Conde Rivera O; Santos Nores J; Borrajo Prol M; Pérez Melón C Nefrologia; 2010; 30(5):589-91. PubMed ID: 20882098 [No Abstract] [Full Text] [Related]
19. A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study. McQuillan RF; Chiu E; Nessim S; Lok CE; Roscoe JM; Tam P; Jassal SV Clin J Am Soc Nephrol; 2012 Feb; 7(2):297-303. PubMed ID: 22134627 [TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study). Jassal SV; Lok CE; Perit Dial Int; 2008; 28(1):67-72. PubMed ID: 18178950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]